These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 20388863)
1. Refill adherence to oral hypoglycemic agents and glycemic control in veterans. Kim N; Agostini JV; Justice AC Ann Pharmacother; 2010 May; 44(5):800-8. PubMed ID: 20388863 [TBL] [Abstract][Full Text] [Related]
2. The Effect of Early Response to GLP-1 RA Therapy on Long-Term Adherence and Persistence Among Type 2 Diabetes Patients in the United States. Durden E; Liang M; Fowler R; Panton UH; Mocevic E J Manag Care Spec Pharm; 2019 Jun; 25(6):669-680. PubMed ID: 30896359 [TBL] [Abstract][Full Text] [Related]
3. Measuring Persistence to Oral Hypoglycemic Agents in Type 2 Diabetic Veterans. Kim N; Agostini J; Justice A J Pharm Technol; 2009 Jul; 25(4):223-229. PubMed ID: 21779543 [TBL] [Abstract][Full Text] [Related]
4. Adherence with pharmacotherapy for type 2 diabetes: a retrospective cohort study of adults with employer-sponsored health insurance. Hertz RP; Unger AN; Lustik MB Clin Ther; 2005 Jul; 27(7):1064-73. PubMed ID: 16154485 [TBL] [Abstract][Full Text] [Related]
5. Effectiveness of Targeted Insulin-Adherence Interventions for Glycemic Control Using Predictive Analytics Among Patients With Type 2 Diabetes: A Randomized Clinical Trial. Lauffenburger JC; Lewey J; Jan S; Makanji S; Ferro CA; Krumme AA; Lee J; Ghazinouri R; Haff N; Choudhry NK JAMA Netw Open; 2019 Mar; 2(3):e190657. PubMed ID: 30874782 [TBL] [Abstract][Full Text] [Related]
6. Longitudinal effects of medication nonadherence on glycemic control. Egede LE; Gebregziabher M; Echols C; Lynch CP Ann Pharmacother; 2014 May; 48(5):562-70. PubMed ID: 24586059 [TBL] [Abstract][Full Text] [Related]
7. Impact of medication adherence and persistence on clinical and economic outcomes in patients with type 2 diabetes treated with liraglutide: a retrospective cohort study. Buysman EK; Liu F; Hammer M; Langer J Adv Ther; 2015 Apr; 32(4):341-55. PubMed ID: 25832470 [TBL] [Abstract][Full Text] [Related]
8. Relationship between patient medication adherence and subsequent clinical inertia in type 2 diabetes glycemic management. Grant R; Adams AS; Trinacty CM; Zhang F; Kleinman K; Soumerai SB; Meigs JB; Ross-Degnan D Diabetes Care; 2007 Apr; 30(4):807-12. PubMed ID: 17259469 [TBL] [Abstract][Full Text] [Related]
9. Effect of prescription refill on quality of care among patients with type 2 diabetes: an exploratory study. Wang JY; Lee SH; Lee IT; Chen JD; Sheu WH Diabetes Res Clin Pract; 2014 Jul; 105(1):110-8. PubMed ID: 24842246 [TBL] [Abstract][Full Text] [Related]
10. Prescription of oral hypoglycemic agents for patients with type 2 diabetes mellitus: A retrospective cohort study using a Japanese hospital database. Tanabe M; Motonaga R; Terawaki Y; Nomiyama T; Yanase T J Diabetes Investig; 2017 Mar; 8(2):227-234. PubMed ID: 27549920 [TBL] [Abstract][Full Text] [Related]
11. Oral antidiabetic medication adherence and glycemic control in managed care. Rozenfeld Y; Hunt JS; Plauschinat C; Wong KS Am J Manag Care; 2008 Feb; 14(2):71-5. PubMed ID: 18269302 [TBL] [Abstract][Full Text] [Related]
12. Medication Regimen Complexity and A1C Goal Attainment in Underserved Adults With Type 2 Diabetes. Yeh A; Shah-Manek B; Lor KB Ann Pharmacother; 2017 Feb; 51(2):111-117. PubMed ID: 28042735 [TBL] [Abstract][Full Text] [Related]
13. Longitudinal differences in glycemic control by race/ethnicity among veterans with type 2 diabetes. Egede LE; Mueller M; Echols CL; Gebregziabher M Med Care; 2010 Jun; 48(6):527-33. PubMed ID: 20473215 [TBL] [Abstract][Full Text] [Related]
14. Improved Glycemic Control Outcomes Regardless of Mental Health Disorders in a Pharmacist-Endocrinologist Diabetes Intense Medical Management (DIMM) "Tune Up" Clinic. Morello CM; Nguyen T; Tao L; Hirsch JD Ann Pharmacother; 2020 Sep; 54(9):858-865. PubMed ID: 32100551 [No Abstract] [Full Text] [Related]
15. Diabetes medication persistence, different medications have different persistence rates. Shani M; Lustman A; Vinker S Prim Care Diabetes; 2017 Aug; 11(4):360-364. PubMed ID: 28420583 [TBL] [Abstract][Full Text] [Related]
16. Medication adherence and racial differences in A1C control. Adams AS; Trinacty CM; Zhang F; Kleinman K; Grant RW; Meigs JB; Soumerai SB; Ross-Degnan D Diabetes Care; 2008 May; 31(5):916-21. PubMed ID: 18235050 [TBL] [Abstract][Full Text] [Related]
17. Association of Potentially Modifiable Diabetes Care Factors With Glycemic Control in Patients With Insulin-Treated Type 2 Diabetes. Lauffenburger JC; Lewey J; Jan S; Lee J; Ghazinouri R; Choudhry NK JAMA Netw Open; 2020 Jan; 3(1):e1919645. PubMed ID: 31968115 [TBL] [Abstract][Full Text] [Related]
18. Persistence with injectable antidiabetic agents in members with type 2 diabetes in a commercial managed care organization. Cooke CE; Lee HY; Tong YP; Haines ST Curr Med Res Opin; 2010 Jan; 26(1):231-8. PubMed ID: 19921965 [TBL] [Abstract][Full Text] [Related]
19. Impact of depression on utilization patterns of oral hypoglycemic agents in patients newly diagnosed with type 2 diabetes mellitus: a retrospective cohort analysis. Kalsekar ID; Madhavan SS; Amonkar MM; Douglas SM; Makela E; Elswick BL; Scott V Clin Ther; 2006 Feb; 28(2):306-18. PubMed ID: 16678652 [TBL] [Abstract][Full Text] [Related]
20. The Impact of Dual Health Care System Use for Obtaining Prescription Medications on Nonadherence in Veterans With Type 2 Diabetes. Taber DJ; Ward R; Axon RN; Walker RJ; Egede LE; Gebregziabher M Ann Pharmacother; 2019 Jul; 53(7):675-682. PubMed ID: 30724092 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]